NCT03380455View on ClinicalTrials.gov

Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

January 29, 2018

Study Completion Date

January 29, 2018

Conditions
Healthy Subjects
Interventions
DRUG

Lucerastat

Single oral dose of 500 mg lucerastat under fasted conditions

DRUG

Cimetidine

Twice daily oral dose of 800 mg cimetidine under fasted conditions

Trial Locations (1)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03380455 - Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects | Biotech Hunter | Biotech Hunter